![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: John Wiley & Sons Inc
E-ISSN: 1097-0045|78|5|353-364
ISSN: 0270-4137
Source: THE PROSTATE, Vol.78, Iss.5, 2018-04, pp. : 353-364
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
THE PROSTATE, Vol. 75, Iss. 12, 2015-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Diethylstilboestrol (1 mg) in the Management of Castration-Resistant Prostate Cancer
Urologia Internationalis, Vol. 94, Iss. 3, 2014-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Safety and efficacy of 2‐weekly cabazitaxel in metastatic castration‐resistant prostate cancer
BJU INTERNATIONAL, Vol. 121, Iss. 2, 2018-02 ,pp. :